Contracted thalamic shape is associated with early development of levodopa-induced dyskinesia in Parkinson’s disease

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2045-2322
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Contracted thalamic shape is associated with early development of levodopa-induced dyskinesia in Parkinson’s disease ; volume:12 ; number:1 ; day:25 ; month:7 ; year:2022 ; pages:1-9 ; date:12.2022
Scientific reports ; 12, Heft 1 (25.7.2022), 1-9, 12.2022

Urheber
Yoo, Han Soo
Lee, Eun-Chong
Chung, Seok Jong
Ye, Byoung Seok
Sohn, Young H.
Seong, Joon-Kyung
Lee, Phil Hyu
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1038/s41598-022-16747-6
URN
urn:nbn:de:101:1-2022100619312451593231
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:35 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Yoo, Han Soo
  • Lee, Eun-Chong
  • Chung, Seok Jong
  • Ye, Byoung Seok
  • Sohn, Young H.
  • Seong, Joon-Kyung
  • Lee, Phil Hyu
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease

Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease

Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease

Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease

24-hour levodopa-carbidopa intestinal gel may reduce troublesome dyskinesia in advanced Parkinson’s disease

24-hour levodopa-carbidopa intestinal gel may reduce troublesome dyskinesia in advanced Parkinson’s disease

Risk factors of levodopa-induced dyskinesia in Parkinson’s disease: results from the PPMI cohort

Risk factors of levodopa-induced dyskinesia in Parkinson’s disease: results from the PPMI cohort

Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease

Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease

Altered perivascular spaces in subcortical white matter in Parkinson’s disease patients with levodopa-induced dyskinesia

Altered perivascular spaces in subcortical white matter in Parkinson’s disease patients with levodopa-induced dyskinesia

Safety and tolerability of IRL790 in Parkinson’s disease with levodopa-induced dyskinesia—a phase 1b trial

Safety and tolerability of IRL790 in Parkinson’s disease with levodopa-induced dyskinesia—a phase 1b trial

Cognitive impairment and levodopa induced dyskinesia in Parkinson’s disease: a longitudinal study from the PACOS cohort

Cognitive impairment and levodopa induced dyskinesia in Parkinson’s disease: a longitudinal study from the PACOS cohort

Predicting levodopa-induced dyskinesia

Predicting levodopa-induced dyskinesia

Mavoglurant (AFQ056) for the treatment of levodopa-induced dyskinesia in patients with Parkinson’s disease: a meta-analysis

Mavoglurant (AFQ056) for the treatment of levodopa-induced dyskinesia in patients with Parkinson’s disease: a meta-analysis

The NONRATT023402.2/rno-miR-3065-5p/NGFR axis affects levodopa-induced dyskinesia in a rat model of Parkinson’s disease

The NONRATT023402.2/rno-miR-3065-5p/NGFR axis affects levodopa-induced dyskinesia in a rat model of Parkinson’s disease

Dyskinesia-hyperpyrexia syndrome in Parkinson’s disease: a systematic review

Dyskinesia-hyperpyrexia syndrome in Parkinson’s disease: a systematic review

Verbundene Objekte